Method of treating disorders of the melatoninergic system and a certain benzofuran containing compound
AssigneeAdir et Compagnie
InventorsDaniel Lesieur, Eric Fourmaintraux, Patrick Depreux, Philippe Delagrange, Pierre Renard, Beatrice Guardiola-Lemaitre
Life of this patent
Estimating the term…
Abstract
The invention relates to a compound selected from those of formula (I): ##STR1## in which: R.sub.1, R.sub.2, R.sub.3 and A are as defined in the description, and Medicinal product containing the same useful for treating a disorder of the melatoninergic system.
Claims9
A method-of-treating a mammal afflicted with a disorder of the melatoninergic system comprising the step of administering to the said mammal an amount of a compound selected from the group consisting of those of formula (I):
- ##STR44## in which R.sub.1 represents alkyl,
- A forms, with the benzene ring to which it is attached, a cyclic group selected from the group consisting of benzofuran and 2,3-dihydrobenzofuran,
- R.sub.2 represents hydrogen,
- R.sub.3 represents ##STR45## with X representing oxygen and R.sub.4 representing alkyl, it being understood that, in the description of formula (I),
- the term "alkyl" denotes a linear or branched group containing 1 to 6 carbon atoms, inclusive, and the enantiomers and diastereoisomers thereof, which is effective for alleviating the said disorder.
A compound which is N-2-(5-ethylbenzofuran-3-yl)ethyl!acetamide.
Dependencies are inferred from the claim text.